🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Markets · 15 min delay
NBI4,187.6â–˛ +1.14%
PFE28.42â–Ľ -0.38%
AZN74.18â–˛ +0.81%
NVO103.55â–˛ +2.07%
ROG261.40â–Ľ -0.55%
ABBV174.92â–˛ +0.29%
EUR/USD1.0842â–Ľ -0.12%
ISEQ9,241.3â–˛ +0.62%
NBI4,187.6â–˛ +1.14%
PFE28.42â–Ľ -0.38%
AZN74.18â–˛ +0.81%
NVO103.55â–˛ +2.07%
ROG261.40â–Ľ -0.55%
ABBV174.92â–˛ +0.29%
EUR/USD1.0842â–Ľ -0.12%

Search Results

Found 411 results for "AI" across articles, medicines, trials, companies and the glossary

The Pill That Promised a Revolution: Why Eli Lilly's Foundayo Is Launching Slower Than Wall Street Expected
Industry News
The Pill That Promised a Revolution: Why Eli Lilly's Foundayo Is Launching Slower Than Wall Street Expected
Jefferies has revised its debut-quarter US sales estimate for Eli Lilly's oral GLP-1 drug Foundayo (orforglipron) down to $71 million — well below the Wall Street consensus of $130 million and sharply below its own prior estimate of $85 million. With weekly prescriptions hovering around 20,000 and Novo Nordisk's oral Wegovy outpacing it on trajectory, the first oral non-peptide GLP-1 for obesity is generating a very different story than the hype suggested.
5 hrs ago
Speed Over Scrutiny? The High-Stakes Gamble Behind the NHS's New Fast-Track Drug Pilots
Industry News
Speed Over Scrutiny? The High-Stakes Gamble Behind the NHS's New Fast-Track Drug Pilots
The UK government and the pharmaceutical industry have launched a series of pilot schemes designed to accelerate NHS patient access to innovative medicines — a direct consequence of the US-UK pharmaceutical trade arrangement that has already rewritten the terms of how Britain prices, approves, and funds new drugs. But with a BMJ analysis warning of £45 billion in diverted NHS resources and up to 229,000 excess deaths by 2036, the pilots are arriving in the middle of one of the most contested healthcare policy disputes in a generation.
5 hrs ago
Cork MedTech Innovator NeuroBell Secures $5.5M to Accelerate Launch of AI Neonatal Seizure Monitor Luna
Pharma & MedTech
Cork MedTech Innovator NeuroBell Secures $5.5M to Accelerate Launch of AI Neonatal Seizure Monitor Luna
NeuroBell, a spin-out from University College UCC, has closed a $5.5 million (€4.8 million) funding round led by Elkstone to secure US regulatory clearance and commercialize its AI-powered neonatal seizure detection device, Luna.
1 days ago
Tapestry VC Closes $80M Fund III Backed by British Business Bank to Target Repeat Founders
AI & Digital Innovation
Tapestry VC Closes $80M Fund III Backed by British Business Bank to Target Repeat Founders
Co-founded by Patrick Murphy and David Kelly, Tapestry VC has announced the closing of its $80 million Fund III, tripling its capital base with support from OpenAI CFO Sarah Friar and the British Business Bank.
1 days ago
AI Real Estate Pioneer Build Raises $8.5M Seed Round to Automate Infrastructure Workflows
AI & Digital Innovation
AI Real Estate Pioneer Build Raises $8.5M Seed Round to Automate Infrastructure Workflows
Build, a startup co-founded by James Stirrat-Ellis and Ben McClusky, has secured $8.5 million in seed funding led by Index Ventures to expand Dougie, its AI platform for real estate infrastructure workflows.
1 days ago
GovTech Startup Xylo Raises ÂŁ2.8M Led by CapitalT to Solve Local Council Planning Bottlenecks
AI & Digital Innovation
GovTech Startup Xylo Raises ÂŁ2.8M Led by CapitalT to Solve Local Council Planning Bottlenecks
Co-founded by Habs Isabelle Kim and Dermot O'Riordan, government technology startup Xylo has raised ÂŁ2.8 million in pre-seed funding to deploy AI agents that speed up local planning departments.
1 days ago
Data Integrity and Quality Oversight: Analyzing the FDA Warning Letter for Sanofi's Waterford Site
Regulatory
Data Integrity and Quality Oversight: Analyzing the FDA Warning Letter for Sanofi's Waterford Site
Following a January 2026 inspection, the FDA has issued a formal warning letter to Genzyme Ireland Limited in Waterford, citing data integrity concerns, uncontrolled checklists, and quality unit oversight gaps in the manufacturing of Thymoglobulin and Altuviiio.
2 days ago
A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals
Pharma & MedTech
A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals
In a landmark world-first, Irish-founded Chanelle McCoy Health has received official regulatory approvals from the Saudi Food and Drug Authority and confirmation of safety under EU Novel Food guidelines for its Pureis® Ultra Pure CBD range.
3 days ago
The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026
Regulatory Affairs
The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026
A comprehensive technical report detailing the top 10 trends in Good Manufacturing Practice (GMP), sterile manufacturing, GAMP 5, Quality 4.0, and continuous manufacturing currently reshaping the global pharmaceutical landscape.
5 days ago
Funding the Future: Inside the €75k Women TechEU and £10M Createch Grants for Startups and SMEs
Biotech News
Funding the Future: Inside the €75k Women TechEU and £10M Createch Grants for Startups and SMEs
An in-depth analysis of two newly opened funding opportunities—Women TechEU and Innovate UK's Next Wave Createch—designed to support early-stage deep tech and creative technology innovators across Europe and the UK.
5 days ago
FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings
Regulatory
FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings
The FDA has issued a formal warning letter to Sanofi's Waterford facility, Genzyme Ireland Limited, citing data integrity breaches, discarded quality records, and botched deviation investigations in the production of haemophilia drug Altuviiio and transplant therapy Thymoglobulin.
5 days ago
Cold Chain Management and Good Distribution Practice (GDP) for Biologics and Vaccines
Regulatory Affairs
Cold Chain Management and Good Distribution Practice (GDP) for Biologics and Vaccines
An academic analysis of temperature-sensitive supply chains, GDP compliance, distribution monitoring, and shipping deviation management.
30 Jun 2026
Understanding the Common Technical Document (CTD) Structure for Global Regulatory Submissions
Regulatory Affairs
Understanding the Common Technical Document (CTD) Structure for Global Regulatory Submissions
An explanation of the 5 modules of the ICH Common Technical Document (CTD) format required for global drug marketing authorization applications.
30 Jun 2026
Media Fill Validation: Guidelines for Simulating Aseptic Liquid Processing Operations
Tools & Resources
Media Fill Validation: Guidelines for Simulating Aseptic Liquid Processing Operations
A review of aseptic process simulation (APS), growth media selection, incubation parameters, and contamination limits in media fill validation.
29 Jun 2026
Navigating Global Price Controls: How the US Inflation Reduction Act and Evolving EU Policies Shape R&D in 2026
Regulatory
Navigating Global Price Controls: How the US Inflation Reduction Act and Evolving EU Policies Shape R&D in 2026
As global health systems enforce tighter pricing controls under the US IRA and EU health technology updates, biopharma majors are restructuring their R&D portfolios to manage clinical risks.
29 Jun 2026
An Introduction to Lyophilization (Freeze-Drying) Technology and Cycle Development in Biopharma
Tools & Resources
An Introduction to Lyophilization (Freeze-Drying) Technology and Cycle Development in Biopharma
An academic analysis of the freeze-drying process, sublimation phases, critical chamber controls, and lyophilized formulation parameters.
29 Jun 2026
Data Integrity in the Pharmaceutical Quality Control Laboratory: ALCOA+ Principles Explained
Regulatory Affairs
Data Integrity in the Pharmaceutical Quality Control Laboratory: ALCOA+ Principles Explained
An educational review of data integrity requirements in pharma QC, covering ALCOA+ principles, audit trails, and data security.
29 Jun 2026
Out of Specification (OOS) Investigations: Step-by-Step Root Cause Analysis and CAPA Guidelines
Tools & Resources
Out of Specification (OOS) Investigations: Step-by-Step Root Cause Analysis and CAPA Guidelines
A structured tutorial on handling quality control laboratory OOS results, conducting Phase I/II investigations, and implementing corrective actions.
29 Jun 2026
Therapeutic Hotspots of 2026: Evolving Pipelines in Antibody-Drug Conjugates (ADCs) and GLP-1 Obesity Platforms
Biotech News
Therapeutic Hotspots of 2026: Evolving Pipelines in Antibody-Drug Conjugates (ADCs) and GLP-1 Obesity Platforms
Global research pipelines and venture capital inflows are concentrating in targeted cancer therapy with ADCs and next-generation cardiometabolic GLP-1 oral weight-loss compounds.
29 Jun 2026
Computer Systems Validation (CSV): Implementing the GAMP 5 Lifecycle Framework in Modern Plants
Tools & Resources
Computer Systems Validation (CSV): Implementing the GAMP 5 Lifecycle Framework in Modern Plants
A guide to validating computerized lab and production systems using the GAMP 5 V-model lifecycle, risk assessments, and electronic records compliance.
29 Jun 2026
Master's in Pharmacy & Pharmaceutical Sciences in Ireland: Complete 2026 Guide for International Students
News
Master's in Pharmacy & Pharmaceutical Sciences in Ireland: Complete 2026 Guide for International Students
An exhaustive guide detailing postgraduate Level 9 pharmaceutical master's programs across Irish universities, covering tuition fees, eligibility criteria, and requirements for international applicants.
29 Jun 2026
The Science of Cleanroom Classification: Understanding ISO 14644-1 Standards in Sterile Processing
Tools & Resources
The Science of Cleanroom Classification: Understanding ISO 14644-1 Standards in Sterile Processing
An academic overview of cleanroom design parameters, particulate limits under ISO 14644-1, laminar airflow dynamics, and Grade A-D cleanroom zoning.
29 Jun 2026
From Pilots to Infrastructure: How AI is Becoming the Core Operating System for Biopharma R&D in 2026
AI & Digital Innovation
From Pilots to Infrastructure: How AI is Becoming the Core Operating System for Biopharma R&D in 2026
Artificial intelligence has evolved from sandbox pilot projects to become the default operating system driving drug discovery, clinical trials, and sterile manufacturing.
29 Jun 2026
Securing AI Agents on Amazon Bedrock: Free Compliance & Security Session Scheduled for July 9th
AI & Digital Innovation
Securing AI Agents on Amazon Bedrock: Free Compliance & Security Session Scheduled for July 9th
AWS and security firm DarkHunt are hosting a free 45-minute online training session on July 9th focused on proving compliance under the EU AI Act and securing generative AI agents in production.
29 Jun 2026
B2B Scaling Roundtable: Fieldfisher to Host Dublin Tech Founders on July 1st
Industry News
B2B Scaling Roundtable: Fieldfisher to Host Dublin Tech Founders on July 1st
Legal firm Fieldfisher will host a scaling roundtable for B2B founders and sales leaders in Dublin on July 1st, featuring legal guidance from Jamie Woodcock and leadership coaching from Fergus McFadden.
29 Jun 2026
Two Irish Startups Accepted into Y Combinator Summer 2026 Batch: Blueprints and ProvenMetal Secure $500k Funding
AI & Digital Innovation
Two Irish Startups Accepted into Y Combinator Summer 2026 Batch: Blueprints and ProvenMetal Secure $500k Funding
Two promising Irish startups, prediction market trading assistant Blueprints and AI benchtop X-ray hardware builder ProvenMetal, have been accepted into the prestigious Y Combinator Summer 2026 cohort in San Francisco, securing $500,000 in seed backing each.
29 Jun 2026
MedTech Pioneer CroĂ­Valve Closes $27 Million Series B Expansion to Advance Transcatheter Tricuspid Heart Valve Treatment
Pharma & MedTech
MedTech Pioneer CroĂ­Valve Closes $27 Million Series B Expansion to Advance Transcatheter Tricuspid Heart Valve Treatment
Dublin-based medical device developer CroĂ­Valve has secured a $27 million expansion of its Series B round, combining equity funding led by BGF and state grants to accelerate US and EU clinical trials for its DUO Adapt System.
29 Jun 2026
Ubotica Secures $11 Million to Roll Out Satellite-Based Orbital AI Maritime Intelligence Platform
AI & Digital Innovation
Ubotica Secures $11 Million to Roll Out Satellite-Based Orbital AI Maritime Intelligence Platform
Space-tech leader Ubotica has closed an $11 million funding round led by Act Venture Capital and Greencode Ventures to scale its real-time Live Maritime Intelligence platform powered by direct satellite AI processing.
29 Jun 2026
HR Duo Raises €1.6 Million from Puma Growth Partners and Enterprise Ireland to Accelerate UK Expansion
Industry News
HR Duo Raises €1.6 Million from Puma Growth Partners and Enterprise Ireland to Accelerate UK Expansion
Workforce management SaaS platform HR Duo has closed a €1.6 million funding round backed by Puma Growth Partners and Enterprise Ireland to scale its automated HR and compliance services for SMEs in frontline industries.
29 Jun 2026
Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions
News
Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions
Explore the highest-ranked Irish universities, including Trinity College Dublin, UCD, UCC, and University of Galway, looking at their global ranking positions, location, and key research strengths.
28 Jun 2026
The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs
News
The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs
From Enterprise Ireland feasibility grants and Local Enterprise Office funding to seed venture capital and angel networks, this is the ultimate blueprint for starting and scaling a business in Ireland.
28 Jun 2026
Addiction Counsellors of Ireland Launch Strategic Plan 2026–2029 to Prepare for CORU Regulation
News
Addiction Counsellors of Ireland Launch Strategic Plan 2026–2029 to Prepare for CORU Regulation
Presented at the ACI’s Annual General Meeting in Carlow by Minister Jennifer Murnane O’Connor and ACI Board member John Devlin, the new three-year strategy focuses on workforce recognition, professional development, and regulatory transitions.
28 Jun 2026
Ireland Funds €426,000 Behavioral App for Alcohol Reduction Amid Record Treatment Demand
News
Ireland Funds €426,000 Behavioral App for Alcohol Reduction Amid Record Treatment Demand
As the Health Research Board (HRB) reports a record 8,798 alcohol treatment cases in 2025, Minister Murnane O’Connor has announced funding for an evidence-based digital intervention tool under the Sláintecare Integration Innovation Fund.
28 Jun 2026
EU PEACEPLUS Funds €2.4M All-Island Public Health Knowledge Hub to Unite Cross-Border Population Data
News
EU PEACEPLUS Funds €2.4M All-Island Public Health Knowledge Hub to Unite Cross-Border Population Data
Launched in Dundalk, the three-year Public Health Knowledge Hub (PHKH) project brings together the Institute of Public Health, Trinity College Dublin, and Ulster University to build the first-ever harmonised cross-border public health data portal.
28 Jun 2026
The Irish Distortion: How Multinational Pharma Giants Warped the EU’s Economic Landscape
AI & Digital Innovation
The Irish Distortion: How Multinational Pharma Giants Warped the EU’s Economic Landscape
Ireland’s status as a corporate hub for global pharmaceutical multinationals has created a unique statistical paradox—masking true economic health and dragging the EU’s GDP into negative territory in the first quarter of 2026. We examine the tax structures, tariff-hedging inventory builds, and supply chain strategies driving this anomaly.
28 Jun 2026
Life Science PR in 2026: The Complete Guide to Building Authority, Winning Media Coverage, and Controlling Your Narrative
Regulatory
Life Science PR in 2026: The Complete Guide to Building Authority, Winning Media Coverage, and Controlling Your Narrative
A definitive 5,000-word guide to public relations for pharmaceutical, biotech, and MedTech professionals. Learn how to build a PR strategy from scratch, which tools to use, how to write for journalists and LinkedIn, and the exact frameworks used by the world's leading life science communications teams.
27 Jun 2026
LinkedIn PR for Life Science & Pharma: The Definitive Guide to Building Credibility, Authority, and Visibility in 2026
AI & Digital Innovation
LinkedIn PR for Life Science & Pharma: The Definitive Guide to Building Credibility, Authority, and Visibility in 2026
A practitioner-level guide to building genuine professional authority on LinkedIn as a pharmaceutical, biotech, or MedTech professional. Covers profile architecture, content strategy, engagement tactics, thought leadership frameworks, and the exact playbooks used by the most followed life science voices on the platform.
27 Jun 2026
Ireland Family Reunification 2026: The Complete Guide to Financial Thresholds, Waiting Periods, How to Apply, and What Every Sponsor Must Know
Regulatory
Ireland Family Reunification 2026: The Complete Guide to Financial Thresholds, Waiting Periods, How to Apply, and What Every Sponsor Must Know
A detailed, practical guide to Ireland's Non-EEA Family Reunification Policy as updated in 2026. Covers the new financial thresholds for all sponsor categories, country-specific waiting periods, step-by-step application process, and a comprehensive pre-application checklist - essential reading for pharmacists, healthcare workers, and life science professionals bringing family to Ireland.
27 Jun 2026
UK Looks to Spain’s "Catalonia Blueprint" to Boost Global Clinical Trials Competitiveness
Industry News
UK Looks to Spain’s "Catalonia Blueprint" to Boost Global Clinical Trials Competitiveness
As global competition intensifies, UK life sciences leaders are examining Spain’s thriving Catalonia region for strategies to attract commercial sponsors, streamline regulatory reviews, and revitalize Britain’s clinical trials sector.
25 Jun 2026
Pharmaceutical Regulatory Update 2026: EU, UK, FDA & Global Changes Explained
Regulatory Affairs
Pharmaceutical Regulatory Update 2026: EU, UK, FDA & Global Changes Explained
A massive wave of regulatory reform is sweeping the global pharma industry in 2026. From the EU's most significant legislative overhaul in decades to the FDA's sweeping Operation TrialBlazer, we break down what quality, manufacturing, and regulatory teams need to know to stay compliant.
25 Jun 2026
Eli Lilly Adapts Direct-to-Patient Model for UK Market with LillyDirect Launch
Industry News
Eli Lilly Adapts Direct-to-Patient Model for UK Market with LillyDirect Launch
Eli Lilly has successfully brought its LillyDirect service to the UK. Adapted to comply with strict local regulations, the service partners with regulated healthcare organizations to offer secure, anti-counterfeit delivery of high-demand therapies like Mounjaro directly to patients' doors.
25 Jun 2026
Galen’s Penthrox Inhaler Secures Expanded UK License for Paediatric Trauma Pain
Regulatory Affairs
Galen’s Penthrox Inhaler Secures Expanded UK License for Paediatric Trauma Pain
Northern Ireland-based Galen has received an expanded UK license for its emergency pain relief inhaler, Penthrox (methoxyflurane). The self-administered "green whistle" is now officially approved for use in conscious children aged six and older suffering from trauma-associated pain.
25 Jun 2026
From Farming to Pharma: The History of Ireland’s Life Sciences Revolution
Industry News
From Farming to Pharma: The History of Ireland’s Life Sciences Revolution
How did a nation once defined by agriculture and emigration transform into the world’s third-largest exporter of pharmaceuticals? We trace the deliberate policy shifts, educational reforms, and FDI strategies that built Ireland’s booming life sciences ecosystem.
25 Jun 2026
Navigating Ireland’s Pharma Dependency: Strategies for Policy and Talent in an Uncertain Era
Regulatory Affairs
Navigating Ireland’s Pharma Dependency: Strategies for Policy and Talent in an Uncertain Era
With pharmaceuticals making up 20% of Ireland’s GDP, the nation’s reliance on the industry brings immense economic benefit but notable risks. We explore how Ireland must adapt its policy, manage geopolitical headwinds, and aggressively attract skilled labour to secure its future.
25 Jun 2026
Beyond the Headline: Are Irish Pharma Workers Truly the Highest Paid in Europe?
Industry News
Beyond the Headline: Are Irish Pharma Workers Truly the Highest Paid in Europe?
Recent reports suggest Irish pharma workers are the highest paid in Europe, but a deeper dive reveals a more complex reality. We analyze compensation packages, tax regimes, and cost of living across Europe’s top pharmaceutical hubs.
25 Jun 2026
Egypt, Ireland Explore Industrial Cooperation in Pharmaceuticals, Renewable Energy, and Advanced Technologies
Industry News
Egypt, Ireland Explore Industrial Cooperation in Pharmaceuticals, Renewable Energy, and Advanced Technologies
Egypt’s Minister of Industry and Ireland’s Ambassador discuss strategic collaboration across pharmaceuticals, renewable energy, and technology sectors, aiming to leverage Irish expertise for local manufacturing.
25 Jun 2026
The 2026 Obesity Power Rankings: Which Pharma Giants Can Break the Lilly-Novo Duopoly?
Industry News
The 2026 Obesity Power Rankings: Which Pharma Giants Can Break the Lilly-Novo Duopoly?
With the obesity market projected to exceed $130 billion by 2034, we analyze the top 10 pharmaceutical companies vying for dominance. Explore our comprehensive Power Rankings assessing pipeline depth, clinical differentiation, and commercial infrastructure.
25 Jun 2026
Viewpoint: Why Ireland’s Pharma Sector is Immune to the Global 'Carbon Leakage' Exodus
Industry News
Viewpoint: Why Ireland’s Pharma Sector is Immune to the Global 'Carbon Leakage' Exodus
A new Central Bank of Ireland study reveals that while global manufacturers flee strict climate laws, Ireland's biopharma sector remains stubbornly rooted. Here is what this means for the future of Irish FDI.
25 Jun 2026
Helus Pharma Secures US$50M Offering as MDD Trial Surpasses 86% Enrollment
Industry News
Helus Pharma Secures US$50M Offering as MDD Trial Surpasses 86% Enrollment
Helus Pharma announces a $50 million offering to progress Phase 3 trials for their novel serotonergic agonists, alongside major clinical milestones and leadership updates.
25 Jun 2026
NICE Recommends Libtayo for Advanced Cervical Cancer in England and Wales
Industry News
NICE Recommends Libtayo for Advanced Cervical Cancer in England and Wales
Around 90 women with advanced cervical cancer in the UK could be eligible for treatment with Regeneron's immunotherapy Libtayo each year, following a green light from NICE.
25 Jun 2026